Latest On Abcam plc (ABCZY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2021-03-10 06:12 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-12-04 18:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 23:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 02:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-23 03:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 08:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 19:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 07:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 23:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 17:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:17 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 11:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 19:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 03:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 22:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:56 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-10 02:45 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 23:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 23:33 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 23:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-19 06:06 EST | Dividend | A dividend of $0.05 has been announced on Mar 10, 2020. It will be paid May 1, 2020 with an ex-dividend date of Mar 19, 2020. | Neutral | |
| 2020-03-11 02:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 06:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 00:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 02:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-21 01:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 01:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-14 15:48 EST | Stock Split | A stock split has occured on Dec 1, 2010 with a split factor of 5:1. | Neutral | |
About Abcam plc (ABCZY):
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.
General
- Name Abcam plc
- Symbol ABCZY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 1,600
- Last Split Factor5:1
- Last Split Date2010-12-01
- Fiscal Year EndJune
- Web URLhttp://www.abcam.com
View More
Valuation
- Trailing PE 48.62
- Forward PE 92.59
- Price/Sales (Trailing 12 Mt.) 12.22
- Price/Book (Most Recent Quarter) 5.46
- Enterprise Value Revenue 17.47
- Enterprise Value EBITDA 150.76
View More
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -1%
- Return on Assets 3%
- Earnings Per Share $0.40
- Revenue Per Share $0
- Gross Profit 180.2 million
- Quarterly Earnings Growth 6.7%
View More
Highlights
- Market Capitalization 4.35 billion
- Book Value Per Share $2.27
View More
Share Statistics
- Shares Outstanding 216.23 million
- Shares Float 186.53 million
- % Held by Insiders <1%
View More
Technicals
- Beta 0.4
- 52 Week High $24.69
- 52 Week Low $11.95
- 50 Day Moving Average 22.34
- 200 Day Moving Average 18.93
View More
Dividends
- Forward Annual Dividend Rate $0.15
- Forward Annual Dividend Yield 0.8%
- Payout Ratio 152%
- Dividend Date 2020-05-01
- ExDividend Date 2020-03-19
- Dividend Per Share $0.16
View More
Abcam plc (ABCZY) Dividend Calendar:
ABCZY's last dividend payment was made to shareholders on May 1, 2020.
Abcam plc pays out 152% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Abcam plc (ABCZY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-12-31 | $N/A | $0.04 | $0.00 | |
| 2020-06-30 | 2020-09-30 | $N/A | $0.03 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $N/A | -$0.04 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $69.1 million | -$0.04 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $69.1 million | $0.08 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $67.6 million | $0.08 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $67.6 million | $0.05 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $62.35 million | $0.05 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $62.35 million | $0.09 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $6.73 million | $0.09 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $7.19 million | $0.10 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $56.25 million | $0.10 | $0.00 | |
| 2017-09-30 | 2017-12-31 | $56.25 million | $0.11 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $74.63 million | $0.11 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $71.93 million | $0.07 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $51.26 million | $0.07 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $51.26 million | $0.06 | $0.00 | |
| 2016-06-30 | 2016-09-30 | $0.06 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.07 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.07 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.06 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.06 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.08 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.07 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.07 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.07 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.08 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.07 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.07 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.07 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.07 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.07 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.06 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.06 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.05 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.05 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.05 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.05 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.06 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.06 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.05 | $0.00 |
Abcam plc (ABCZY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | 4.5 million |
| Income Before Tax | N/A | N/A | N/A | N/A | 13 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 30.35 million |
| Gross Profit | N/A | N/A | N/A | N/A | 48.15 million |
| Ebit | N/A | N/A | N/A | N/A | 13.3 million |
| Operating Income | N/A | N/A | N/A | N/A | 13.3 million |
| Income Tax Expense | 1.05 million | 1.05 million | -2 million | -2 million | -50000 |
| Total Revenue | N/A | N/A | N/A | N/A | 69.1 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 20.95 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -300000 |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 13.05 million |
| Net Income Applicable to Common Shares | 5.85 million | 5.85 million | -6.8 million | -6.8 million | 13.05 million |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Oct 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | -1.1 million | N/A | -1.1 million |
| Change to Liabilities | 350000 | 350000 | 850000 | 850000 | 850000 |
| Total Cash Flow from Investing Activities | -64.65 million | -64.65 million | -9.4 million | -9.4 million | -9.4 million |
| Net Borrowings | -500000 | -500000 | 50.6 million | 50.6 million | 50.6 million |
| Total Cash Flow from Financial Activities | N/A | N/A | 41.8 million | N/A | 41.8 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | 51.4 million | N/A | 51.4 million |
| Total Cash from Operating Activities | 11.7 million | 11.7 million | 19.8 million | 19.8 million | 19.8 million |
| Depreciation | N/A | N/A | 6.6 million | N/A | 6.6 million |
| Other Cash Flow from Investing Activities | -250000 | -250000 | 300000 | 300000 | 300000 |
| Change to Inventory | N/A | N/A | -2.3 million | N/A | -2.3 million |
| Change to Account Receivables | N/A | N/A | 3.55 million | N/A | 3.55 million |
| Other Cash Flow from Financing Activities | -550000 | -550000 | -300000 | -300000 | -300000 |
| Change to Net Income | 10.25 million | 10.25 million | -1.95 million | -1.95 million | -1.95 million |
| Capital Expenditures | N/A | N/A | 3.95 million | N/A | 3.95 million |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | 308.8 million | N/A | 232.6 million |
| Total Stockholder Equity | N/A | N/A | 502.6 million | N/A | 389.8 million |
| Other Current Liabilities | 1.5 million | 1.5 million | N/A | N/A | 1.2 million |
| Total Assets | N/A | N/A | 811.4 million | N/A | 622.4 million |
| Common Stock | 500000 | 500000 | N/A | N/A | 400000 |
| Other Current Assets | 300000 | 300000 | N/A | 400000 | 2.1 million |
| Retained Earnings | 272.3 million | 272.3 million | 255.7 million | 255.7 million | 269.3 million |
| Other Liabilities | 28.1 million | 28.1 million | N/A | 28.7 million | 16.4 million |
| Other Assets | 15.6 million | 15.6 million | N/A | 13.7 million | 8.1 million |
| Cash | N/A | N/A | 187.3 million | N/A | 189.9 million |
| Total Current Liabilities | 55.1 million | 55.1 million | 159.6 million | N/A | 148.7 million |
| Other Stockholder Equity | 94.2 million | 94.2 million | N/A | 110.8 million | 94.9 million |
| Property, Plant & Equipment | 157.5 million | 157.5 million | N/A | 164.7 million | 108.2 million |
| Total Current Assets | 307.5 million | 307.5 million | 278.8 million | N/A | 277.4 million |
| Long Term Investments | N/A | N/A | N/A | N/A | 3.1 million |
| Net Tangible Assets | 290.9 million | 290.9 million | N/A | 155.4 million | 164.2 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 43.4 million | 43.4 million | 40.7 million | N/A | 39.5 million |
| Accounts Payable | 46.5 million | 46.5 million | 43.8 million | N/A | 39.6 million |
Abcam plc (ABCZY) Chart:
Abcam plc (ABCZY) News:
Below you will find a list of latest news for Abcam plc (ABCZY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Abcam plc (ABCZY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Abcam plc (ABCZY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-23 | DRS | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1492074/000095012320007146/0000950123-20-007146-index.htm |
| 2020-08-28 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1492074/000095012320009400/0000950123-20-009400-index.htm |
| 2020-09-16 | DRS/A | Draft Registration Statement | https://www.sec.gov/Archives/edgar/data/1492074/000095012320009770/0000950123-20-009770-index.htm |
| 2011-12-16 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1492074/000101915511000691/0001019155-11-000691-index.htm |
| 2020-10-02 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1492074/000119312520262444/0001193125-20-262444-index.htm |
| 2020-10-19 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1492074/000119312520271612/0001193125-20-271612-index.htm |
| 2020-10-19 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1492074/000119312520271836/0001193125-20-271836-index.htm |
| 2020-10-21 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1492074/000119312520273300/0001193125-20-273300-index.htm |
| 2020-10-21 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1492074/000119312520273683/0001193125-20-273683-index.htm |
| 2020-10-21 | F-1MEF | Registration statement to add securities to prior Form F-1 registration [Rule 462(b)] | https://www.sec.gov/Archives/edgar/data/1492074/000119312520273841/0001193125-20-273841-index.htm |
| 2020-10-22 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1492074/000119312520274479/0001193125-20-274479-index.htm |
| 2020-11-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1492074/000119312520284594/0001193125-20-284594-index.htm |
| 2020-11-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1492074/000119312520285548/0001193125-20-285548-index.htm |
| 2010-05-17 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1492074/000119380510001411/0001193805-10-001411-index.htm |
| 2011-08-30 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1492074/000119380511001680/0001193805-11-001680-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1492074/000119380517002631/0001193805-17-002631-index.htm |
| 2020-10-21 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1492074/000135445720000613/0001354457-20-000613-index.htm |
| 2011-06-08 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1492074/000149207411000003/0001492074-11-000003-index.htm |
| 2012-04-27 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1492074/000149207412000006/0001492074-12-000006-index.htm |
| 2020-03-12 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/1492074/000149207420000003/0001492074-20-000003-index.htm |
| 2014-11-06 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1492074/000157104914005889/0001571049-14-005889-index.htm |
| 2020-10-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1492074/999999999520002933/9999999995-20-002933-index.htm |